Sati et al. (1999) concluded that myeloma cells produce TNF-α but not IL-1β. But a later study showed that elevated IL-1β mRNA levels were positively associated with bone lesions in patient biopsies (Donovan et al., 2002). The gene discussed is IL1B; the disease is plasma cell myeloma.